Calamos Advisors’s Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share MTAL.WS Stock Holding History

Calamos Advisors’s Portfolio MTAL.WS Stock Details MTAL.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-166,666	Closed	-$353K	–	1015
2024 Q1	$353K	Hold	166,666	–	–	﹤0.01%	716
2023 Q4	$285K	Hold	166,666	–	–	﹤0.01%	738
2023 Q3	$335K	Hold	166,666	–	–	﹤0.01%	731
2023 Q2	$233K	Hold	166,666	–	–	﹤0.01%	779
2023 Q1	$122K	Hold	166,666	–	–	﹤0.01%	897
2022 Q4	$81.8K	Hold	166,666	–	–	﹤0.01%	969
2022 Q3	$62K	Buy	+166,666	New	+$69.3K	﹤0.01%	1083

Calamos Advisors's MTAL.WS Position: Q2 2024 in Review

Calamos Advisors sold out of Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share (MTAL.WS) in Q2 2024, closing a stake of 166,666 shares — an estimated $353K sold.

Calamos Advisors first reported a position in MTAL.WS in Q3 2022 and held it in 7 quarters. The position peaked at $353K in Q1 2024. 0 funds tracked by Wall St. Rank hold MTAL.WS as of Q2 2024.

Calamos Advisors reported no remaining Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share position as of Q2 2024 after selling out during the quarter.
Calamos Advisors sold 166,666 Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share shares in Q2 2024, an estimated $353K.
Calamos Advisors first reported a position in Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share in Q3 2022 and held it in 7 quarters.
Calamos Advisors's Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share position peaked at $353K in Q1 2024.
0 funds tracked by Wall St. Rank held Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share as of Q2 2024.

Based on Calamos Advisors's 13F filing for Q2 2024, filed 25 Jul 2024.